136 related articles for article (PubMed ID: 30666440)
21. Nonsurgical management of oropharyngeal, laryngeal, and hypopharyngeal cancer: the Fox Chase Cancer Center experience.
Andrews G; Lango M; Cohen R; Feigenberg S; Burtness B; Mehra R; Ahmed S; Nicolaou N; Gaughan J; Ridge JA
Head Neck; 2011 Oct; 33(10):1433-40. PubMed ID: 21928415
[TBL] [Abstract][Full Text] [Related]
22. Long-term survival after distant metastasis in patients with oropharyngeal cancer.
McBride SM; Busse PM; Clark JR; Wirth LJ; Ancukiewicz M; Chan AW
Oral Oncol; 2014 Mar; 50(3):208-12. PubMed ID: 24387975
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer.
Haughey BH; Sinha P
Laryngoscope; 2012 Sep; 122 Suppl 2():S13-33. PubMed ID: 22926949
[TBL] [Abstract][Full Text] [Related]
24. Biologic importance and prognostic significance of selected clinicopathological parameters in patients with oral and oropharyngeal squamous cell carcinoma, with emphasis on smoking, protein p16(INK4a) expression, and HPV status.
Laco J; Nekvindova J; Novakova V; Celakovsky P; Dolezalova H; Tucek L; Vosmikova H; Vosmik M; Neskudlova T; Cermakova E; Hacova M; Sobande FA; Ryska A
Neoplasma; 2012; 59(4):398-408. PubMed ID: 22489695
[TBL] [Abstract][Full Text] [Related]
25. Pathologically determined tumor volume vs pathologic T stage in the prediction of outcome after surgical treatment of oropharyngeal squamous cell carcinoma.
Nixon IJ; Palmer FL; Lakin P; Kattan MM; Lee NY; Ganly I
JAMA Otolaryngol Head Neck Surg; 2013 Nov; 139(11):1151-5. PubMed ID: 24092047
[TBL] [Abstract][Full Text] [Related]
26. Oropharyngeal squamous cell carcinoma in the veteran population: Association with traditional carcinogen exposure and poor clinical outcomes.
Sandulache VC; Hamblin J; Lai S; Pezzi T; Skinner HD; Khan NA; Dioun SM; Hartman C; Kramer J; Chiao E; Zhou X; Zevallos JP
Head Neck; 2015 Sep; 37(9):1246-53. PubMed ID: 24801106
[TBL] [Abstract][Full Text] [Related]
27. Tumor volume reduction rate measured during adaptive definitive radiation therapy as a potential prognosticator of locoregional control in patients with oropharyngeal cancer.
Lee H; Ahn YC; Oh D; Nam H; Kim YI; Park SY
Head Neck; 2014 Apr; 36(4):499-504. PubMed ID: 23780633
[TBL] [Abstract][Full Text] [Related]
28. Survival outcomes in patients with oropharyngeal cancer treated with carboplatin/paclitaxel and concurrent radiotherapy.
Roskies M; Kay-Rivest E; Mascarella MA; Sultanem K; Mlynarek A; Hier M
J Otolaryngol Head Neck Surg; 2016 Oct; 45(1):50. PubMed ID: 27724969
[TBL] [Abstract][Full Text] [Related]
29. Impact of chemotherapy regimen on treatment outcomes in patients with HPV-associated oropharyngeal cancer with T4 disease treated with definitive concurrent chemoradiation.
Bhattasali O; Ryoo JJ; Thompson LDR; Abdalla IA; Chen J; Iganej S
Oral Oncol; 2019 Aug; 95():74-78. PubMed ID: 31345397
[TBL] [Abstract][Full Text] [Related]
30. Primary tumor volume is an important predictor of clinical outcomes among patients with locally advanced squamous cell cancer of the head and neck treated with definitive chemoradiotherapy.
Strongin A; Yovino S; Taylor R; Wolf J; Cullen K; Zimrin A; Strome S; Regine W; Suntharalingam M
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1823-30. PubMed ID: 21549516
[TBL] [Abstract][Full Text] [Related]
31. Neck metastases in oropharyngeal cancer: Necessity and extent of bilateral treatment.
Dziegielewski PT; O'Connell DA; Szudek J; Barber B; Joshi A; Harris JR; Seikaly H
Head Neck; 2013 Oct; 35(10):1461-7. PubMed ID: 23008129
[TBL] [Abstract][Full Text] [Related]
32. Outcome of per oral wide excision of T1-2 N0 localized squamous cell cancer of the buccal mucosa--analysis of 156 cases.
Hakeem AH; Pradhan SA; Tubachi J; Kannan R
Laryngoscope; 2013 Jan; 123(1):177-80. PubMed ID: 22952001
[TBL] [Abstract][Full Text] [Related]
33. Recurrence patterns after postoperative radiotherapy for squamous cell carcinoma of the pharynx and larynx.
Iizuka Y; Yoshimura M; Inokuchi H; Matsuo Y; Nakamura A; Mizowaki T; Hirano S; Kitamura M; Tateya I; Hiraoka M
Acta Otolaryngol; 2015 Jan; 135(1):96-102. PubMed ID: 25351439
[TBL] [Abstract][Full Text] [Related]
34. Treatment outcome of oropharyngeal squamous cell carcinoma through propensity score analysis.
Lau F; Lisatchok M; Tamanini JB; Gazmenga FP; Texeira DNA; Couto EV; Chone CT
Braz J Otorhinolaryngol; 2023; 89(6):101335. PubMed ID: 37813007
[TBL] [Abstract][Full Text] [Related]
35. Definitive chemoradiation for locoregional recurrences of esophageal cancer after primary curative treatment.
Jeene PM; Versteijne E; van Berge Henegouwen MI; Bergmann JJ; Geijsen ED; Muller K; van Laarhoven HW; Hulshof MC
Dis Esophagus; 2017 Feb; 30(2):1-5. PubMed ID: 27766725
[TBL] [Abstract][Full Text] [Related]
36. Radiation therapy for early-stage carcinoma of the oropharynx.
Selek U; Garden AS; Morrison WH; El-Naggar AK; Rosenthal DI; Ang KK
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):743-51. PubMed ID: 15183477
[TBL] [Abstract][Full Text] [Related]
37. Outcome of patients after treatment for a squamous cell carcinoma of the oropharynx.
Röösli C; Tschudi DC; Studer G; Braun J; Stoeckli SJ
Laryngoscope; 2009 Mar; 119(3):534-40. PubMed ID: 19235752
[TBL] [Abstract][Full Text] [Related]
38. Salvage surgery for recurrent oropharyngeal cancer: post-operative oncologic and functional outcomes.
Culié D; Benezery K; Chamorey E; Ettaiche M; Fernandez J; Poissonnet G; Riss JC; Hannoun-Lévi JM; Chand ME; Leysalle A; Saada E; Sudaka A; Haudebourg J; Demard F; Santini J; Peyrade F; Dassonville O; Bozec A
Acta Otolaryngol; 2015; 135(12):1323-9. PubMed ID: 26223741
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathological and immunohistochemical evaluation of oral and oropharyngeal squamous cell carcinoma in Chilean population.
Rivera C; González-Arriagada WA; Loyola-Brambilla M; de Almeida OP; Coletta RD; Venegas B
Int J Clin Exp Pathol; 2014; 7(9):5968-77. PubMed ID: 25337241
[TBL] [Abstract][Full Text] [Related]
40. Externally validated HPV-based prognostic nomogram for oropharyngeal carcinoma patients yields more accurate predictions than TNM staging.
Rios Velazquez E; Hoebers F; Aerts HJ; Rietbergen MM; Brakenhoff RH; Leemans RC; Speel EJ; Straetmans J; Kremer B; Lambin P
Radiother Oncol; 2014 Dec; 113(3):324-30. PubMed ID: 25443497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
